摘要
日益增加的多药耐药性已威胁公众健康。多药耐药外排泵的过度表达是耐药菌耐药的主要机制之一。由于抗菌药物的主动外排起着重要的作用,在调解耐药性的细菌,外排泵的抑制似乎是一种恢复抗菌效力的有效方法。近年来,为了解决由外排泵介导的多药耐药这一严重的问题,已经发现和测试了大量的外排泵抑制剂,包括天然产物,抗生素和合成分子。本综述主要介绍了在寻找能够抑制革兰氏阳性和革兰阴性菌外排泵的新分子最近取得的成就,特别强调了金黄色葡萄球菌、铜绿假单胞菌和AcrAB-TolC肠杆菌外排泵的天然和合成抑制剂。并主要关注于其作用机制、构效关系及与临床抗生素的协同作用。
关键词: 多药耐药,外排泵,泵抑制剂,NorA,MexAB-OprM,AcrAB-TolC
图形摘要
Current Drug Targets
Title:Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria
Volume: 17 Issue: 6
Author(s): Yinhu Wang, Henrietta Venter and Shutao Ma
Affiliation:
关键词: 多药耐药,外排泵,泵抑制剂,NorA,MexAB-OprM,AcrAB-TolC
摘要: The increasing multi-drug resistance has become a major threat to the public health. Overexpression of multidrug efflux pumps is one of the major mechanisms of drug resistance in bacteria. Since active efflux of antibacterial agents plays a significant role in mediating drug resistance in bacteria, the inhibition of efflux pumps appears to be a promising strategy to restore antibacterial potency. In recent years, in order to address this grave problem of multiple drug resistance mediated by efflux pump, a large number of efflux pump inhibitors have been discovered and tested, including natural products, antibiotics and synthetic molecules. This review mainly describes recent achievements in the search for new molecules that are able to inhibit efflux pumps in both Gram-positive and Gram-negative bacteria, in particular emphasis on natural and synthetic inhibitors of the NorA efflux pump in Staphylococcus aureus, MexAB-OprM efflux pump in Pseudomonas aeruginosa, and AcrAB-TolC efflux pump in Enterobacteriaceae, giving special attention to their mechanisms of action, structureactivity relationships and synergetic effect with clinically available antibiotics.
Export Options
About this article
Cite this article as:
Yinhu Wang, Henrietta Venter and Shutao Ma , Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria , Current Drug Targets 2016; 17 (6) . https://dx.doi.org/10.2174/1389450116666151001103948
DOI https://dx.doi.org/10.2174/1389450116666151001103948 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pro-Inflammatory Cytokines and their Actions on the Metabolic Disturbances Associated with Cancer: Implications in Cachexia
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeted Therapy in Colorectal Cancer: Current Status and Future Challenges
Current Medicinal Chemistry Mechanisms of Angiogenesis: Perspectives from Antiangiogenic Tumor Therapies
Current Angiogenesis (Discontinued) Multicolor-FISH Approaches for the Characterization of Human Chromosomes in Clinical Genetics and Tumor Cytogenetics
Current Genomics Therapeutic Potential of Autotaxin/Lysophospholipase D Inhibitors
Current Drug Targets Patent Selections:
Recent Patents on Biomarkers Guggulsterone for Chemoprevention of Cancer
Current Pharmaceutical Design Fibroblast Activation Protein in Remodeling Tissues
Current Molecular Medicine Gastrin: An Acid-Releasing, Proliferative and Immunomodulatory Peptide?
Mini-Reviews in Medicinal Chemistry Circulating Advanced Oxidation Protein Products as Oxidative Stress Biomarkers and Progression Mediators in Pathological Conditions Related to Inflammation and Immune Dysregulation
Current Medicinal Chemistry Base Excision Repair, the Redox Environment and Therapeutic Implications
Current Molecular Pharmacology Farnesylated Proteins as Anticancer Drug Targets: From Laboratory to the Clinic
Current Medicinal Chemistry - Anti-Cancer Agents The Ubiquitin-Proteasome System (UPS) and the Mechanism of Action of Bortezomib
Current Pharmaceutical Design Nano-zinc Coordination with the Ligands of Carboplatin, Oxaliplatin and Nedaplatin. Synthesis, Characterization and Biological Properties
Letters in Organic Chemistry Role of AGEs in Diabetic Nephropathy
Current Pharmaceutical Design Click-Chemistry Reactions in Radiopharmaceutical Chemistry: Fast & Easy Introduction of Radiolabels into Biomolecules for In Vivo Imaging
Current Medicinal Chemistry The Chemical Defensive System in the Pathobiology of Idiopathic Environment- Associated Diseases
Current Drug Metabolism Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design WISP1 (CCN4) Autoregulates its Expression and Nuclear Trafficking of β-Catenin during Oxidant Stress with Limited Effects upon Neuronal Autophagy
Current Neurovascular Research Methylation of ZNF331 Promotes Cell Invasion and Migration in Human Esophageal Cancer
Current Protein & Peptide Science